AG
ALNY icon

Artal Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-936
Closed -$166K 93
2023
Q3
$166K Hold
936
0.01% 94
2023
Q2
$178K Buy
+936
New +$178K 0.01% 110
2022
Q3
Sell
-600,000
Closed -$87.5M 132
2022
Q2
$87.5M Sell
600,000
-50,000
-8% -$7.29M 4.67% 6
2022
Q1
$106M Hold
650,000
4.44% 6
2021
Q4
$110M Sell
650,000
-50,000
-7% -$8.48M 2.99% 6
2021
Q3
$132M Sell
700,000
-50,000
-7% -$9.44M 2.96% 8
2021
Q2
$127M Hold
750,000
2.58% 8
2021
Q1
$106M Sell
750,000
-50,000
-6% -$7.06M 1.87% 11
2020
Q4
$104M Hold
800,000
2.23% 9
2020
Q3
$116M Sell
800,000
-100,000
-11% -$14.6M 2.83% 6
2020
Q2
$133M Sell
900,000
-200,000
-18% -$29.6M 3.73% 5
2020
Q1
$120M Buy
1,100,000
+100,000
+10% +$10.9M 5.06% 4
2019
Q4
$115M Buy
1,000,000
+300,000
+43% +$34.6M 4.45% 3
2019
Q3
$56.3M Buy
700,000
+300,000
+75% +$24.1M 2.26% 9
2019
Q2
$29M Sell
400,000
-50,000
-11% -$3.63M 1.17% 18
2019
Q1
$42.1M Sell
450,000
-50,000
-10% -$4.67M 1.72% 13
2018
Q4
$36.5M Sell
500,000
-100,000
-17% -$7.29M 1.35% 9
2018
Q3
$52.5M Sell
600,000
-50,000
-8% -$4.38M 1.37% 7
2018
Q2
$64M Buy
650,000
+50,000
+8% +$4.92M 1.36% 4
2018
Q1
$71.5M Buy
600,000
+150,000
+33% +$17.9M 0.89% 6
2017
Q4
$57.2M Buy
450,000
+200,000
+80% +$25.4M 0.86% 4
2017
Q3
$29.4M Sell
250,000
-25,000
-9% -$2.94M 0.51% 7
2017
Q2
$21.9M Sell
275,000
-25,000
-8% -$1.99M 0.38% 11
2017
Q1
$15.4M Sell
300,000
-200,000
-40% -$10.3M 0.34% 12
2016
Q4
$18.7M Sell
500,000
-100,000
-17% -$3.74M 0.42% 11
2016
Q3
$40.7M Sell
600,000
-110,000
-15% -$7.46M 0.81% 5
2016
Q2
$39.4M Buy
710,000
+110,000
+18% +$6.1M 0.81% 5
2016
Q1
$37.7M Buy
600,000
+125,000
+26% +$7.85M 0.73% 5
2015
Q4
$44.7M Buy
475,000
+40,000
+9% +$3.77M 0.84% 5
2015
Q3
$35M Sell
435,000
-20,000
-4% -$1.61M 0.78% 6
2015
Q2
$54.5M Sell
455,000
-15,000
-3% -$1.8M 2.35% 4
2015
Q1
$49.1M Buy
470,000
+70,000
+18% +$7.31M 2.27% 5
2014
Q4
$38.8M Buy
400,000
+100,000
+33% +$9.7M 1.36% 5
2014
Q3
$23.4M Hold
300,000
0.86% 8
2014
Q2
$19M Buy
300,000
+95,000
+46% +$6M 0.77% 7
2014
Q1
$13.8M Buy
205,000
+80,000
+64% +$5.37M 0.5% 13
2013
Q4
$8.04M Buy
+125,000
New +$8.04M 0.29% 16